October 2019 - Volume 41 - Issue 5 : Therapeutic Drug Monitoring

Secondary Logo

Journal Logo

October 2019 - Volume 41 - Issue 5
pp: 551-692

TDM in Oncology

Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group–Therapeutic Drug Monitoring Protocol for a Prospective Study

Groenland, Stefanie L.; van Eerden, Ruben A. G.; Verheijen, Remy B.; More

Therapeutic Drug Monitoring. 41(5):561-567, October 2019.

Evaluation of Medication Adherence and Pharmacokinetics of Dasatinib for Earlier Molecular Response in Japanese Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Pilot Study

Iwamoto, Takuya; Monma, Fumihiko; Ohishi, Kohshi; More

Therapeutic Drug Monitoring. 41(5):575-581, October 2019.

Development and Validation of a Sensitive UHPLC-MS/MS–Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients

Muller, Ittai B.; Lin, Marry; Struys, Eduard A.; More

Therapeutic Drug Monitoring. 41(5):598-606, October 2019.

Estimation of Blood Sirolimus Concentration Based on Tacrolimus Concentration/Dose Normalized by Body Weight Ratio in Lung Transplant Patients

Kikuchi, Masafumi; Shigeta, Kensuke; Tanaka, Masaki; More

Therapeutic Drug Monitoring. 41(5):615-619, October 2019.

Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab

De Keyser, Eline; Busard, Celine I.; Lanssens, Sven; More

Therapeutic Drug Monitoring. 41(5):634-639, October 2019.

Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis

Huerta-García, Ana P.; Medellín-Garibay, Susanna E.; Salazar-González, Raúl A.; More

Therapeutic Drug Monitoring. 41(5):648-656, October 2019.